Treating HFrEF: Is Clinical Practice the Same Around the World?
Published: 20 November 2020
-
Views:
60
-
Likes:
7
-
Views:
60
-
Likes:
7
Overview
In this Satellite Symposium from the e-SPACE Heart Failure Global Web-Conference, Stefan Anker, John JV McMurray, Justin Ezekowitz, Piotr Ponikowski and Carolyn Lam discuss the clinical practices for treating HFrEF around the world.
This satellite symposium was organised by Amgen, Cytokinetics & Servier.
Learning Objectives
- Understanding Global Challenges in Clinical Practice to Achieving Guideline–Directed Medical Therapy (GDMT) for HFrEF Patients Across the Globe Including Underrepresented and Minority Populations
- Identify Similarities and Common Residual Risk Patterns Despite Regional Guidelines and Local Clinical Practice
- Evaluate Regional Unmet Needs, Advancements in Management, and Share Regional Best Practice to Achieving GDMT
- Discussion on Fundamental Pathways of HFrEF Pathophysiology and Progression
Agenda
- Treating HFrEF in the Americas: Best Practices and Improvement Opportunities (Justin Ezekowitz)
- Are Challenges to Achieving Guideline-Directed Medical Therapy Different in Europe? (Piotr Ponikowski)
- Panel Discussion (Stefan Anker, Carolyn Lam, John McMurray, Justin Ezekowitz & Piotr Ponikowski)
More from this programme
Part 1
Treating HFrEF in the Americas: Best Practices and Improvement Opportunities
Part 2
Are Challenges to Achieving Guideline-Directed Medical Therapy Different in Europe?
Part 3
Panel Discussion
| 1 session | |
| Panel Discussion | Watch now |
